Cita APA (7a ed.)

N, G., & L, B. (2021). Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press.

Cita Chicago Style (17a ed.)

N, Giustini, y Bazhenova L. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press, 2021.

Cita MLA (8a ed.)

N, Giustini, y Bazhenova L. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press, 2021.